Gastroesophageal Junction Carcinoma — Trials

Gastroesophageal Junction Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

707 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 231
Recruiting: 126
Ph III recruiting: 18
Growth YoY: +44.2%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 32.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (86)

clinicaltrialsPublishedShowing 151–156 of 156 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05642338	A Multicenter Prospective Cohort Study Comparing Random Biopsies Versus Wide-Area Transepithelial Brush-Sampling (WATS) for Surveillance of Barrett's Esophagus, the WATS-EURO2 Study(WATSEURO2)	recruiting	—	416	Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER	1	Dec 8, 2022	clinicaltrials
NCT05188313	TRAstuzumab and Pertuzumab for HER2+ Resectable Oesophageal Cancer(TRAP-2)	recruiting	Phase 3	376	Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)